Cited by 329Mobile Health and mHealth ApplicationsStatistical Methods in Clinical TrialsDigital Mental Health Interventions

Digitizing clinical trials

Open access
Inan, O. T., Tenaerts, P., Prindiville, S. A., Reynolds, H. R., Dizon, D. S., Cooper-Arnold, K., Turakhia, M., Pletcher, M. J. +12 more·2020·npj Digital Medicine

Abstract

Clinical trials are a fundamental tool used to evaluate the efficacy and safety of new drugs and medical devices and other health system interventions. The traditional clinical trials system acts as a quality funnel for the development and implementation of new drugs, devices and health system interventions. The concept of a “digital clinical trial” involves leveraging digital technology to improve participant access, engagement, trial-related measurements, and/or interventions, enable concealed randomized intervention allocation, and has the potential to transform clinical trials and to lower their cost. In April 2019, the US National Institutes of Health (NIH) and the National Science Foundation (NSF) held a workshop bringing together experts in clinical trials, digital technology, and digital analytics to discuss strategies to implement the use of digital technologies in clinical trials while considering potential challenges. This position paper builds on this workshop to describe the current state of the art for digital clinical trials including (1) defining and outlining the composition and elements of digital trials; (2) describing recruitment and retention using digital technology; (3) outlining data collection elements including mobile health, wearable technologies, application programming interfaces (APIs), digital transmission of data, and consideration of regulatory oversight and guidance for data security, privacy, and remotely provided informed consent; (4) elucidating digital analytics and data science approaches leveraging artificial intelligence and machine learning algorithms; and (5) setting future priorities and strategies that should be addressed to successfully harness digital methods and the myriad benefits of such technologies for clinical research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41746-020-0302-y

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Digital clinical trials could leverage multiple sources of participants' data to enable automatic phenotyping and subgrouping, which could be useful for adaptive clinical trial designs that use ongoing results to modify the trial in real time.

    “Digital clinical trials could leverage multiple sources of participants' data to enable automatic phenotyping and subgrouping 34 , which could be useful for adaptive clinical trial designs that use ongoing results to modify the trial in real time 39,40 .”

    From Multimodal biomedical AI (2022) · cites this paper as [34]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Data from wearable technology and smartphone-enabled self-reported questionnaires can be useful for monitoring clinical trial patients, identifying adverse events or ascertaining trial outcomes.

    “Data from wearable technology (including heart rate, sleep, physical activity, electrocardiography, oxygen saturation and glucose monitoring) and smartphone-enabled self-reported questionnaires can be useful for monitoring clinical trial patients, identifying adverse events or ascertaining trial outcomes 34 .”

    From Multimodal biomedical AI (2022) · cites this paper as [34]

    The Digital health data collection and Digital monitoring and biomarkers sections describe smartphone-collected patient-reported outcomes, wearable measurements, and their potential use as trial endpoints. Safety monitoring in digital clinical trials says continuous digital data might improve detection of infrequent events and reporting of adverse events. The paper supports the overall claim, but the cited passages do not identify oxygen-saturation monitoring, one of the examples in the citing sentence. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [4]NIH NHLBI. Digital Clinical Trials Workshop: Creating a Vision for the Future. https://www.nhlbi.nih.gov/events/2019/digital-clinical-trials-workshop-creating-vision-future. Accessed 10 Jun 2020.

Cited by

Sorted by citations

Authors
Inan, O. T., Tenaerts, P., Prindiville, S. A., Reynolds, H. R., Dizon, D. S., Cooper-Arnold, K., Turakhia, M., Pletcher, M. J., Preston, K. L., Krumholz, H. M., Marlin, B. M., Mandl, K. D., Klasnja, P., Spring, B., Iturriaga, E., Campo, R., Desvigne-Nickens, P., Rosenberg, Y., Steinhubl, S. R., & Califf, R. M.
Affiliations
  • Georgia Institute of Technology (US)
  • Duke University (US)
  • National Institutes of Health (US)
  • New York University (US)
  • Brown University (US)
  • VA Palo Alto Health Care System (US)
  • University of California, San Francisco (US)
  • Yale New Haven Hospital (US)
  • University of Massachusetts Amherst (US)
  • Boston Children's Hospital (US)
  • University of Michigan (US)
  • Northwestern University (US)
  • Scripps Research Institute (US)
Corresponding author
Inan, O. T.
Venue
npj Digital Medicine
Published
2020-07-31
Volume
3
Issue
1
Pages
101-101
ISSN
2398-6352 (ISSN-L)
OpenAlex
W3046739387
Cited by
329
References
44
Citations by year
2026: 29 · 2025: 55 · 2024: 67 · 2023: 56 · 2022: 70 · 2021: 49 · 2020: 3
FWCI
8.48
Type
journal article
Language
en
Open access
Locations
  • npj Digital Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • National Science Foundation (1922762)
  • American Heart Association
  • Bristol-Myers Squibb
  • Pfizer
  • AstraZeneca
  • Sanofi
  • Yale University
  • Cytokinetics
  • Shenzhen Center for Health Information
  • Verily Life Sciences
  • National Institutes of Health (UL1TR001114)
  • U.S. Food and Drug Administration
  • Abbott Vascular
  • National Heart, Lung, and Blood Institute
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
Keywords
digital health technologies, participant recruitment and retention, mobile health, wearable devices, application programming interfaces, data security and privacy, artificial intelligence in clinical trials, machine learning, data analytics, regulatory oversight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review